Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

TAO Synergies (TAOX) Research & Development (2019 - 2026)

TAO Synergies filings provide 8 years of Research & Development readings, the most recent being $28600.0 for Q1 2026.

  • Quarterly Research & Development fell 52.97% to $28600.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $290009.0 through Mar 2026, down 72.39% year-over-year, with the annual reading at $322225.0 for FY2025, 79.84% down from the prior year.
  • Research & Development hit $28600.0 in Q1 2026 for TAO Synergies, down from $58466.0 in the prior quarter.
  • Across five years, Research & Development topped out at $1.9 million in Q2 2022 and bottomed at $28600.0 in Q1 2026.
  • Average Research & Development over 5 years is $602905.8, with a median of $342068.0 recorded in 2024.
  • The largest annual shift saw Research & Development surged 96.81% in 2022 before it plummeted 90.02% in 2025.
  • TAO Synergies' Research & Development stood at $1.4 million in 2022, then tumbled by 59.1% to $577893.0 in 2023, then decreased by 26.54% to $424508.0 in 2024, then plummeted by 86.23% to $58466.0 in 2025, then crashed by 51.08% to $28600.0 in 2026.
  • Per Business Quant, the three most recent readings for TAOX's Research & Development are $28600.0 (Q1 2026), $58466.0 (Q4 2025), and $54388.0 (Q3 2025).